Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 122 clinical trials
  • 0 views
  • 10 Jan, 2025
  • 1 location
  • 0 views
  • 19 Feb, 2024
  • 2 locations
  • 0 views
  • 19 Feb, 2024
  • 4 locations
Django Migration Testing 12 (DMT)  

Testing

Accepts healthy volunteers
  • 0 views
  • 12 May, 2025
  • 3 locations
PCSK9i in AAA123  

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

  • 0 views
  • 18 Mar, 2025
  • 2 locations
Trial v7.2.1 PS Check  

Trial v7.2.1 PS Check

  • 0 views
  • 19 Jun, 2025
  • 1 location
Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States  

In this program, the investigators will develop novel multimodal neural-behavioral-physiological monitoring tools (software and hardware), and machine learning models for mental states within social processes and beyond. The tools consist of a multimodal skin-like wearable sensor for physiological and biochemical sensing; a conversational virtual human platform to evoke naturalistic social …

  • 0 views
  • 19 Aug, 2025
  • 2 locations
Study for UAT testing_12-Aug  

Study for UAT testing_12-Aug

  • 0 views
  • 13 Aug, 2025
Evaluation of Diabetes and WELLbeing Programme

This study evaluates the impact of 'DWELL' - a 12-week psycho-social education programme designed to help people with type 2 diabetes to better self-manage their condition. Up to 800 patients will participate in the programme, while a non-intervention group will receive routine care for their diabetes

  • 0 views
  • 19 Feb, 2024
  • 5 locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

factor ix
fitusiran
antihemophilic factor
bethesda assay
haemophilia a
  • 0 views
  • 19 Feb, 2024
  • 11 locations